Delivery Order SPE2DB20D1100-SPE2DB25FC6Y9
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,391.00 to AmerisourceBergen Drug Corp for the supply of Nayzilam 5 mg nasal spray. This firm fixed price contract, awarded on August 12, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The delivery order carries no set-aside designation and will be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Nayzilam 5 mg nasal sprays, with a ceiling value of $1,043.25. This is a firm fixed price, competitively awarded contract with no set-aside designation. The delivery order is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 30, 2025. This award represents a child contract under...
- The Defense Logistics Agency awarded a $2,300.41 firm fixed price delivery order to AmerisourceBergen Drug Corp for Nayzilam 5 mg nasal sprays, with an ultimate completion date of May 27, 2025. This non-set-aside competitive award is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- The Defense Logistics Agency awarded a delivery order valued at $2,965.52 to AmerisourceBergen Drug Corp for Nayzilam 5 mg nasal sprays. This firm fixed-price, competitively awarded contract was issued on August 28, 2025, with an ultimate completion date of August 29, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Nayzilam 5 mg nasal sprays, valued at $1,003.08, with a completion date of June 27, 2025. This non-set-aside, firm fixed-price delivery order was competitively awarded and represents a continuation of AmerisourceBergen's ongoing pharmaceutical supply relationship with DLA. The product will be performed and delivered from the contractor's facility in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Nayzilam 5 mg nasal sprays with a contract ceiling value of $1,987.32. This firm fixed-price delivery order, which is non-competitive and set-aside-free, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Nayzilam 5 mg nasal sprays, valued at $1,043.25. The contract was competitively awarded without set-aside designation on August 26, 2025, with an ultimate completion date of August 27, 2025. AmerisourceBergen will perform the work from its corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,827.04 to AmerisourceBergen Drug Corp for the supply of Nayzilam 5 mg nasal sprays under a firm fixed price contract. The award was made on July 24, 2025, with an ultimate completion date of July 25, 2025, and represents a non-competitive, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $3,894.42 to AmerisourceBergen Drug Corp for the supply of Nayzilam 5 mg nasal sprays. This firm fixed price, non-set-aside contract was awarded on May 27, 2025, with an ultimate completion date of May 28, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for $1,100 in Nayzilam 5 mg nasal sprays. This non-set-aside, competitively awarded contract employs firm fixed pricing and maintains a completion deadline of September 15, 2025. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FC6Y9Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,086.50 to AmerisourceBergen Drug Corp for the supply of Nayzilam 5 mg nasal sprays. This competitive award, issued on June 4, 2025, with an ultimate completion date of June 5, 2025, represents a firm fixed-price delivery order with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 through December 2026 and serves as a comprehensive global pharmaceutical support vehicle. AmerisourceBergen Drug Corp functions as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Health Agency and other government entities. The company's role under the SPE2DX contract encompasses a broad portfolio of pharmaceutical products and medical supplies across multiple therapeutic domains, enabling DLA to efficiently procure medications and supplies needed for military healthcare programs worldwide. This specific delivery order for Nayzilam nasal spray—an emergency seizure medication—exemplifies the specialized pharmaceutical commodities supplied through this prime vendor relationship.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 6/4/25 |